Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs

Aliment Pharmacol Ther. 2016 Apr;43(7):840-1. doi: 10.1111/apt.13538.

Authors

P Higgs^{1

2}, C Wright³, M Hellard³

Affiliations

¹ Faculty of Health Sciences, NDRI, Curtin University, Fitzroy, Vic., Australia. peter.higgs@curtin.edu.au.
² Centre for Population Health, The Burnet Institute, Melbourne, Vic., Australia. peter.higgs@curtin.edu.au.
³ Centre for Population Health, The Burnet Institute, Melbourne, Vic., Australia.

PMID: 26932412
DOI: 10.1111/apt.13538

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Female
Hepatitis C, Chronic / drug therapy*
Humans
Interferons / therapeutic use*
Male
Ribavirin / therapeutic use*

Substances

Antiviral Agents
Ribavirin
Interferons